Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia - Iqbal, Zafar; Absar, Muhammad; Al-anazi, Nawaf
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to "almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr Zafar Iqbal obtained his PhD in clinical cancer genetics and post-doctoral training in functional genomics of hematological malignancies. He has published more than 100 articles and abstracts in ISI-indexed journals with international awards. He supervised many PhD and masters students and his groups has discovered some novel leukemic genes.